Now, single jab that could prevent blindnessOctober 13th, 2009 - 12:03 pm ICT by ANI
London, Oct 13 (ANI): A single jab can now prevent people from losing their vision, thanks to researchers at Trinity College Dublin, Ireland, who have developed a new method to inject drug into the blood by weakening the otherwise impermeable blood-retina barrier.
The blood-retina barrier normally prevents molecules in the blood from reaching the retina.
Presently, drugs to treat age-related macular degeneration, the leading cause of blindness in the west, have to be injected into the eyeball once a month, which can cause eye infections and even blindness in 1 out of 50 injections.
But now, researchers led by Matthew Campbell have now restored the vision of mice by temporarily weakening the blood-retina barrier to let drug molecules injected into the blood slip through.
Using a technique called RNA interference (RNAi), they could block the production of claudin-5-a protein that normally helps make the blood-retina barrier impermeable.
“It’s proof of principle,” New Scientist quoted Campbell as saying.
However, RNAi therapy is not yet safe enough for use in people, as it would breach the blood-brain barrier as well as the blood-retina barrier.
The team are already working on a way to block claudin-5 production in the eye only.
This method involves gene therapy using a modified virus that makes the RNA only in the presence of an antibiotic called doxycycline.
With the novel approach, patients would need only one initial injection into their eye to deliver the virus.
Then once a month they would take the antibiotic orally, and two days later the drug to treat blindness would be injected in their blood.
By then the blood-retina barrier would be sufficiently weakened to allow the drug to pass through.
Although the existing drugs to treat age-related macular degeneration would be too big to pass through the barrier, there are other molecules in development that are small enough.
Some of these could be taken orally when the barrier goes down.
The study has been published in Proceedings of the National Academy of Sciences. (ANI)
- Drug-carrying microbot roams through eye - Mar 11, 2011
- Now, a new eye jab that could cure blindness! - Apr 17, 2011
- Drugs to treat age-related blindness - Feb 07, 2011
- Indian origin scientist's gene therapy shows promise in slowing AMD - Apr 30, 2011
- Study identifies key mechanisms in geographic atrophy - Feb 07, 2011
- Grapes can stave off age-related blindness - Jan 15, 2012
- How omega-3 fatty acids keep blindness at bay - Feb 10, 2011
- Prosthetic retina shows promise in restoring sight - May 18, 2012
- Molecule engineered to attack HIV shows positive results - Jan 20, 2011
- Low-cost molecular medicine offers hope for patients with vision loss - Apr 18, 2011
- Novel cell therapy slows down vision loss in eye disease - Apr 08, 2011
- Stem cell therapy for age-related macular degeneration may soon be a reality - Mar 25, 2011
- Researchers isolate protective mechanism to save sight - Nov 17, 2009
- Omega-3 in seafood may protect seniors' eyes - Dec 02, 2010
- Judi Dench battles to save eyesight - Feb 18, 2012
Tags: age related macular degeneration, blood brain barrier, cause of blindness, claudin, doxycycline, drug molecules, eye infections, eyeball, gene therapy, jab, leading cause of blindness, macular degeneration, matthew campbell, mice, new scientist, novel approach, retina, rna interference, trinity college dublin, trinity college dublin ireland